{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:36Z","timestamp":1792181256244,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Global Emerging Infections Surveillance (GEIS) Program, US Department of Defense"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-1021-8","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T19:17:47Z","timestamp":1448997467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia"],"prefix":"10.1186","volume":"14","author":[{"given":"Suwanna","family":"Chaorattanakawee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Lanteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siratchana","family":"Sundrakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritsanai","family":"Yingyuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panita","family":"Gosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitima","family":"Chanarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saowaluk","family":"Wongarunkochakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nillawan","family":"Buathong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soklyda","family":"Chann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worachet","family":"Kuntawunginn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montri","family":"Arsanok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchuor","family":"Char","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanthap","family":"Lon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,2]]},"reference":[{"key":"1021_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4269\/ajtmh.2007.77.160","volume":"77","author":"MK Laufer","year":"2007","unstructured":"Laufer MK, Djimde AA, Plowe CV. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Am J Trop Med Hyg. 2007;77:160\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1021_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1086\/380910","volume":"189","author":"S Jafari","year":"2004","unstructured":"Jafari S, Le Bras J, Bouchaud O, Durand R. Plasmodium falciparum clonal population dynamics during malaria treatment. J Infect Dis. 2004;189:195\u2013203.","journal-title":"J Infect Dis"},{"key":"1021_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2875-8-47","volume":"8","author":"JJ Juliano","year":"2009","unstructured":"Juliano JJ, Randrianarivelojosia M, Ramarosandratana B, Ariey F, Mwapasa V, Meshnick SR. Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar. Malar J. 2009;8:47.","journal-title":"Malar J"},{"key":"1021_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1475-2875-10-380","volume":"10","author":"AM Carlsson","year":"2011","unstructured":"Carlsson AM, Ngasala BE, Dahlstrom S, Membi C, Veiga IM, Rombo L, et al. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Malar J. 2011;10:380.","journal-title":"Malar J"},{"key":"1021_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.meegid.2014.03.012","volume":"24","author":"K Chen","year":"2014","unstructured":"Chen K, Sun L, Lin Y, Fan Q, Zhao Z, Hao M, et al. Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation. Infect Genet Evol. 2014;24:105\u201310.","journal-title":"Infect Genet Evol"},{"key":"1021_CR6","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1086\/592506","volume":"198","author":"SL Nsobya","year":"2008","unstructured":"Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ. Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture. J Infect Dis. 2008;198:1554\u20137.","journal-title":"J Infect Dis"},{"key":"1021_CR7","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1128\/AAC.00161-13","volume":"57","author":"E Ochong","year":"2013","unstructured":"Ochong E, Tumwebaze PK, Byaruhanga O, Greenhouse B, Rosenthal PJ. Fitness consequences of Plasmodium falciparum pfmdr1 polymorphisms inferred from ex vivo culture of Ugandan parasites. Antimicrob Agents Chemother. 2013;57:4245\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"1021_CR8","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/AAC.00687-13","volume":"57","author":"P Lim","year":"2013","unstructured":"Lim P, Dek D, Try V, Eastman RT, Chy S, Sreng S, et al. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011\u20132012: association with molecular markers. Antimicrob Agents Chemother. 2013;57:5277\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"1021_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2875-7-23","volume":"7","author":"R Khositnithikul","year":"2008","unstructured":"Khositnithikul R, Tan-Ariya P, Mungthin M. In vitro atovaquone\/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand. Malar J. 2008;7:23.","journal-title":"Malar J"},{"key":"1021_CR10","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.00366-15","volume":"59","author":"S Chaorattanakawee","year":"2015","unstructured":"Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, et al. Ex vivo drug susceptibility and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia in 2008\u20132013 suggest emerging piperaquine resistance. Antimicrob Agents Chemother. 2015;59:4631\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"1021_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4269\/ajtmh.2011.10-0674","volume":"85","author":"HM Akala","year":"2011","unstructured":"Akala HM, Eyase FL, Cheruiyot AC, Omondi AA, Ogutu BR, Waters NC, et al. Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis. Am J Trop Med Hyg. 2011;85:34\u201341.","journal-title":"Am J Trop Med Hyg"},{"key":"1021_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-4894(83)90091-7","volume":"56","author":"J Bras Le","year":"1983","unstructured":"Le Bras J, Deloron P, Ricour A, Andrieu B, Savel J, Coulaud JP. Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol. 1983;56:9\u201314.","journal-title":"Exp Parasitol"},{"key":"1021_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683\u201391.","journal-title":"Lancet Infect Dis"},{"key":"1021_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/1475-2875-11-325","volume":"11","author":"W Rutvisuttinunt","year":"2012","unstructured":"Rutvisuttinunt W, Chaorattanakawee S, Tyner SD, Teja-Isavadharm P, Se Y, Yingyuen K, et al. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates. Malar J. 2012;11:325.","journal-title":"Malar J"},{"key":"1021_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1475-2875-11-198","volume":"11","author":"SD Tyner","year":"2012","unstructured":"Tyner SD, Lon C, Se Y, Bethell D, Socheat D, Noedl H, et al. Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidinerich protein-2 assay. Malar J. 2012;11:198.","journal-title":"Malar J"},{"key":"1021_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1475-2875-12-239","volume":"12","author":"S Chaorattanakawee","year":"2013","unstructured":"Chaorattanakawee S, Tyner SD, Lon C, Yingyuen K, Ruttvisutinunt W, Sundrakes S, et al. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia. Malar J. 2013;12:239.","journal-title":"Malar J"},{"key":"1021_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2875-4-37","volume":"4","author":"W Chaijaroenkul","year":"2005","unstructured":"Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA. In vitro antimalarial drug susceptibility in Thai border areas from 1998\u20132003. Malar J. 2005;4:37.","journal-title":"Malar J"},{"key":"1021_CR18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"1021_CR19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418\u201320.","journal-title":"J Parasitol"},{"key":"1021_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/1475-2875-12-403","volume":"12","author":"P Gosi","year":"2013","unstructured":"Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, et al. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia. Malar J. 2013;12:403.","journal-title":"Malar J"},{"key":"1021_CR21","first-page":"85","volume":"73","author":"S Viriyakosol","year":"1995","unstructured":"Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Thaithong S, et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ. 1995;73:85\u201395.","journal-title":"Bull World Health Organ"},{"key":"1021_CR22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/infdis\/jiv142","volume":"212","author":"JT Lin","year":"2015","unstructured":"Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, et al. Using amplicon deep sequencing to detect genetic signatures of Plasmodium vivax relapse. J Infect Dis. 2015;212:999\u20131008.","journal-title":"J Infect Dis"},{"key":"1021_CR23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"1021_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-3-9","volume":"3","author":"A Purfield","year":"2004","unstructured":"Purfield A, Nelson A, Laoboonchai A, Congpuong K, McDaniel P, Miller RS, et al. A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Malar J. 2004;3:9.","journal-title":"Malar J"},{"key":"1021_CR25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/jac\/dkm104","volume":"59","author":"CJ Sutherland","year":"2007","unstructured":"Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty JF, Chiodini PL. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. J Antimicrob Chemother. 2007;59:1197\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1021_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.actatropica.2004.09.010","volume":"93","author":"PE Wilson","year":"2005","unstructured":"Wilson PE, Kazadi W, Kamwendo DD, Mwapasa V, Purfield A, Meshnick SR. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop. 2005;93:97\u2013106.","journal-title":"Acta Trop"},{"key":"1021_CR27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0166-6851(82)90034-2","volume":"5","author":"FN Gyang","year":"1982","unstructured":"Gyang FN, Poole B, Trager W. Peptidases from Plasmodium falciparum cultured in vitro. Mol Biochem Parasitol. 1982;5:263\u201373.","journal-title":"Mol Biochem Parasitol"},{"key":"1021_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1550-7408.1978.tb04167.x","volume":"25","author":"SG Langreth","year":"1978","unstructured":"Langreth SG, Jensen JB, Reese RT, Trager W. Fine structure of human malaria in vitro. J Protozool. 1978;25:443\u201352.","journal-title":"J Protozool"},{"key":"1021_CR29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"1021_CR30","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1073\/pnas.1217452110","volume":"110","author":"N Klonis","year":"2013","unstructured":"Klonis N, Xie SC, McCaw JM, Crespo-Ortiz MP, Zaloumis SG, Simpson JA, Tilley L. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc Natl Acad Sci USA. 2013;110:5157\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1021_CR31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.05456-11","volume":"56","author":"F Teuscher","year":"2012","unstructured":"Teuscher F, Chen N, Kyle DE, Gatton ML, Cheng Q. Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition. Antimicrob Agents Chemother. 2012;56:428\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"1021_CR32","doi-asserted-by":"crossref","first-page":"e16940","DOI":"10.1371\/journal.pone.0016940","volume":"6","author":"A Liljander","year":"2011","unstructured":"Liljander A, Bejon P, Mwacharo J, Kai O, Ogada E, Peshu N, Marsh K, Farnert A. Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children. PLoS One. 2011;6:e16940.","journal-title":"PLoS One"},{"key":"1021_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0001-706X(01)00188-7","volume":"81","author":"MT Ekala","year":"2002","unstructured":"Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F. Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants. Acta Trop. 2002;81:33\u201346.","journal-title":"Acta Trop"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-1021-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T23:58:30Z","timestamp":1567382310000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-1021-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"486"}}